Publications by authors named "Ross F Porter"

Claim this Profile
R
RG7774 (Vicasinabin), an orally bioavailable cannabinoid receptor 2 (CB2R) agonist, decreases retinal vascular permeability, leukocyte adhesion, and ocular inflammation in animal models.
Uwe Grether, Richard H Foxton, Sabine Gruener, Claudia Korn, Atsushi Kimbara, Ross F Porter

Front Pharmacolยท July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis